In-call DTMF transport for geostationary mobile satellite communication system
    41.
    发明授权
    In-call DTMF transport for geostationary mobile satellite communication system 有权
    用于对地静止移动卫星通信系统的通话DTMF传输

    公开(公告)号:US06650895B1

    公开(公告)日:2003-11-18

    申请号:US09447696

    申请日:1999-11-23

    CPC classification number: H04B7/19 H04M3/2281 H04M3/533 H04Q1/45

    Abstract: A system and a methodology to improve the end-user quality of service both in terms of response time and reliability for the transport of in-call DTMF signals in wireless systems, particularly in geostationary mobile satellite systems. The methodology encompasses several techniques to provide acceptable end-to-end quality of service for DTMF. A technique is applicable for transport of DTMF in the wireless subscriber to network direction, where DTMF digits are carried in the form of an out-band message. The central part of the technique is to allow multiple key presses in the same message, thereby increasing efficiency and throughput in long-delay environment. Another technique utilizes the vocoder's functionality to carry DTMF in-band, thereby reducing system complexity. The scheme makes the use of an integrated DTMF detector which can classify a given frame of signal into several classes so that the DTMF encoded packet can carry a unique pattern across the air-interface to the voice decoder at AT, which is capable of identifying the pattern. Another technique pertains to the use of a message based DTMF transport between two-ATs on a separate logical channel with a unique Service Access point Identifier (SAPI) providing guaranteed service for DTMF transport in an AT-AT call.

    Abstract translation: 在无线系统,特别是对地静止移动卫星系统中,在无线系统中传输呼叫中的DTMF信号的响应时间和可靠性方面,提高最终用户服务质量的系统和方法。 该方法包括几种为DTMF提供可接受的端到端服务质量的技术。 一种技术适用于将无线用户中的DTMF传输到网络方向,其中DTMF数字以带外消息的形式携带。 该技术的核心部分是允许同一消息中的多个按键按压,从而在长时间延迟环境中提高效率和吞吐量。 另一种技术利用声码器的功能来携带DTMF带内,从而降低系统的复杂性。 该方案使用集成的DTMF检测器,其可以将给定的信号帧分类成多个等级,使得DTMF编码的分组可以在AT的语音解码器的空中接口上携带唯一的模式,其能够识别 模式。 另一种技术涉及在独立的逻辑信道上的两个AT之间使用基于消息的DTMF传输与唯一的服务接入点标识符(SAPI),其在AT-AT呼叫中为DTMF传输提供有保证的服务。

    4-alkenyl-and 4-alkynyloxindoles
    42.
    发明授权
    4-alkenyl-and 4-alkynyloxindoles 失效
    4-链烯基和4-炔氧基吲哚

    公开(公告)号:US06303793B1

    公开(公告)日:2001-10-16

    申请号:US09566054

    申请日:2000-05-05

    Abstract: Disclosed are novel 4-alkenyl- and 4-alkynyl oxindoles having the formula and the pharmaceutically acceptable salts thereof, wherein R1, R2, R3, a, b, and X are as defined herein. These compounds inhibit cyclin-dependent kinases (CDKs), in particular CDK2. These compounds and their pharmaceutically acceptable salts, and prodrugs of said compounds, are anti-proliferative agents useful in the treatment or control of cell proliferative disorders, in particular cancer, more particularly, the treatment or control of breast and colon tumors. Also disclosed are pharmaceutical compositions containing the compounds of formula I and II as well as intermediates useful in the preparation of the compounds of formula I and II.

    Abstract translation: 公开了具有下式的新的4-烯基 - 和4-炔基羟基吲哚及其药学上可接受的盐,其中R1,R2,R3,a,b和X如本文所定义。 这些化合物抑制细胞周期蛋白依赖性激酶(CDK),特别是CDK2。 这些化合物及其药学上可接受的盐和所述化合物的前药是用于治疗或控制细胞增殖性疾病,特别是癌症的抗增殖剂,更具体地,涉及乳腺癌和结肠肿瘤的治疗或控制。 还公开了含有式I和II化合物的药物组合物以及可用于制备式I和II化合物的中间体。

    Smartwatch case
    44.
    外观设计

    公开(公告)号:USD1023790S1

    公开(公告)日:2024-04-23

    申请号:US29869660

    申请日:2023-01-06

    Applicant: Yi Chen

    Designer: Yi Chen

    Abstract: FIG. 1 is a front elevation view of a smartwatch case showing the new design;
    FIG. 2 is a back elevation view thereof;
    FIG. 3 is a left-side view thereof;
    FIG. 4 is a right-side view thereof;
    FIG. 5 is a top plan view thereof;
    FIG. 6 is a bottom plan view thereof;
    FIG. 7 is a perspective view thereof; and,
    FIG. 8 is another perspective view thereof.
    The broken lines depict portions of the smartwatch case and form no part of the claimed design.

    Solar light
    45.
    外观设计

    公开(公告)号:USD885632S1

    公开(公告)日:2020-05-26

    申请号:US29678231

    申请日:2019-01-27

    Applicant: Yi Chen

    Designer: Yi Chen

    Digital scale
    46.
    外观设计

    公开(公告)号:USD872604S1

    公开(公告)日:2020-01-14

    申请号:US29707302

    申请日:2019-09-27

    Applicant: Yi Chen

    Designer: Yi Chen

    Method of forming an array of nanostructures
    47.
    发明授权
    Method of forming an array of nanostructures 有权
    形成纳米结构阵列的方法

    公开(公告)号:US09330910B2

    公开(公告)日:2016-05-03

    申请号:US13882631

    申请日:2011-10-31

    Abstract: A method of forming an array of nanostructures includes forming a plurality of seed points on a surface of a substrate, and growing masks from the seed points to create masked regions of the substrate underlying the masks. A remainder of the substrate comprises an unmasked region. Each mask and masked region increase in size with growth time while the unmasked region of the substrate decreases in size. During the growing, the unmasked region is etched to remove material from the substrate in a depth direction, and, simultaneously, unetched structures are formed from the masked regions of the substrate underlying the masks. Each of the unetched structures has a lateral size that increases with depth.

    Abstract translation: 形成纳米结构阵列的方法包括在衬底的表面上形成多个种子点,以及从种子点生长掩模以产生掩模下面的衬底的掩蔽区域。 衬底的其余部分包括未掩模区域。 每个掩模和掩模区域随着生长时间而增大,而衬底的未掩模区域的尺寸减小。 在生长期间,蚀刻未掩模区域以在深度方向上从衬底去除材料,并且同时从掩模下面的衬底的掩蔽区域形成未蚀刻的结构。 每个未蚀刻的结构具有随深度增加的横向尺寸。

    Camptothecin compound containing stable 7-membered lactone ring, preparation method and use
    48.
    发明授权
    Camptothecin compound containing stable 7-membered lactone ring, preparation method and use 有权
    喜树碱化合物含有稳定的7元内酯环,制备方法和用途

    公开(公告)号:US09115150B2

    公开(公告)日:2015-08-25

    申请号:US14112583

    申请日:2012-04-13

    CPC classification number: C07D491/22

    Abstract: Provided are a camptothecin compound containing 7-membered lactone ring, as shown in general formula I, and pharmaceutically acceptable salt thereof, as well as the preparation method and use thereof. In general formula I, R1 is H, a C1˜C3 alkyl, acetyl or propionyl; R2 is H, a C1˜C6 alkyl, a C3˜C6 cycloalkyl, piperidyl; or a C1˜C6 alkyl substituted by an amino; R3 is H, a C1˜C3 alkyl, or a C1˜C6 alkyl substituted by an amino; R4 is H, a hydroxyl, or a C1˜C6 alkoxy; R5 is H, or a C1˜C6 alkoxyl; or R4 and R5 are linked to each other to form —OCH2O— or —OCH2CH2O—. The compound has good anti-tumor activity, and can be clinically used via oral administration, intravenous injection, and intramuscular injection, among others.

    Abstract translation: 提供了如通式I所示的含有7-元内酯环的喜树碱化合物及其药学上可接受的盐以及其制备方法和用途。 在通式I中,R 1是H,C 1 -C 3烷基,乙酰基或丙酰基; R2是H,C1〜C6烷基,C3〜C6环烷基,哌啶基; 或被氨基取代的C 1-6烷基; R3是H,C1〜C3烷基或被氨基取代的C1〜C6烷基; R4是H,羟基或C1〜C6烷氧基; R5是H或C1〜C6烷氧基; 或R 4和R 5彼此连接形成-OCH 2 O-或-OCH 2 CH 2 O-。 该化合物具有良好的抗肿瘤活性,可以通过口服给药,静脉内注射和肌内注射等临床使用。

Patent Agency Ranking